AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
2ND LINE TREATMENT OPTIONS IN ADVANCED COLORECTAL-CANCER
Authors: STEWART JM MILLWARD MJ ZALCBERG JR
Citation: Jm. Stewart et al., 2ND LINE TREATMENT OPTIONS IN ADVANCED COLORECTAL-CANCER, European journal of cancer, 34(7), 1998, pp. 953-955
5-FLUOROURACIL - A PHARMACOLOGICAL PARADIGM IN THE USE OF CYTOTOXICS
Authors: THOMAS DM ZALCBERG JR
Citation: Dm. Thomas et Jr. Zalcberg, 5-FLUOROURACIL - A PHARMACOLOGICAL PARADIGM IN THE USE OF CYTOTOXICS, Clinical and experimental pharmacology and physiology, 25(11), 1998, pp. 887-895
HORMONE REPLACEMENT THERAPY AND BREAST-CANCER
Authors: ZALCBERG JR SIDEROV J
Citation: Jr. Zalcberg et J. Siderov, HORMONE REPLACEMENT THERAPY AND BREAST-CANCER, Medical journal of Australia, 169(7), 1998, pp. 399-399
ALTERED METHYLATION OF THE HUMAN MDR1 PROMOTER IS ASSOCIATED WITH ACQUIRED MULTIDRUG-RESISTANCE
Authors: KANTHARIDIS P ELOSTA A DESILVA M WALL DMP HU XF SLATER A NADALIN G PARKIN JD ZALCBERG JR
Citation: P. Kantharidis et al., ALTERED METHYLATION OF THE HUMAN MDR1 PROMOTER IS ASSOCIATED WITH ACQUIRED MULTIDRUG-RESISTANCE, Clinical cancer research, 3(11), 1997, pp. 2025-2032
FINAL RESULTS OF A RANDOMIZED TRIAL COMPARING TOMUDEX(R) (RALTITREXED) WITH 5-FLUOROURACIL PLUS LEUCOVORIN IN ADVANCED COLORECTAL-CANCER (VOL 7, PG 961, 1996)
Authors: CUNNINGHAM D ZALCBERG JR RATH U OLIVER I VANCUTSEM E SVENSSON C SEITZ JF HARPER P KERR D PEREZMANGA G
Citation: D. Cunningham et al., FINAL RESULTS OF A RANDOMIZED TRIAL COMPARING TOMUDEX(R) (RALTITREXED) WITH 5-FLUOROURACIL PLUS LEUCOVORIN IN ADVANCED COLORECTAL-CANCER (VOL 7, PG 961, 1996), Annals of oncology, 8(4), 1997, pp. 407-407
SEQUENTIAL EXTRACTION OF DNA AND DNA-BINDING PROTEINS FROM LOW CELL NUMBERS
Authors: ELOSTA S KANTHARIDIS P ZALCBERG JR
Citation: S. Elosta et al., SEQUENTIAL EXTRACTION OF DNA AND DNA-BINDING PROTEINS FROM LOW CELL NUMBERS, BioTechniques, 22(4), 1997, pp. 645-648
CLINICAL ISSUES IN EUTHANASIA
Authors: ZALCBERG JR BUCHANAN JD
Citation: Jr. Zalcberg et Jd. Buchanan, CLINICAL ISSUES IN EUTHANASIA, Medical journal of Australia, 166(3), 1997, pp. 150-152
AUSTRALIAN MULTICENTER PHASE-II TRIAL OF PACLITAXEL IN WOMEN WITH METASTATIC BREAST-CANCER AND PRIOR CHEMOTHERAPY
Authors: MICHAEL M BISHOP JF LEVI JA BELL DR ZALCBERG JR FRIEDLANDER ML OLVER IN SMITH JG TONER GC
Citation: M. Michael et al., AUSTRALIAN MULTICENTER PHASE-II TRIAL OF PACLITAXEL IN WOMEN WITH METASTATIC BREAST-CANCER AND PRIOR CHEMOTHERAPY, Medical journal of Australia, 166(10), 1997, pp. 520-523
EXPRESSION OF MDR1 AND MRP IN THE NORMAL B-CELL HOMOLOG OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: WALL DMP ELOSTA S TZELEPIS D BERTONCELLO I KANTHARIDIS P CHOU ST ZALCBERG JR PARKIN JD
Citation: Dmp. Wall et al., EXPRESSION OF MDR1 AND MRP IN THE NORMAL B-CELL HOMOLOG OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 96(4), 1997, pp. 697-707
CYCLOSPORINE-A AND PSC-833 PREVENT UP-REGULATION OF MDR1 EXPRESSION BY ANTHRACYCLINES IN A HUMAN MULTIDRUG-RESISTANT CELL-LINE
Authors: HU XF SLATER A WALL DM PARKIN JD KANTHARIDIS P ZALCBERG JR
Citation: Xf. Hu et al., CYCLOSPORINE-A AND PSC-833 PREVENT UP-REGULATION OF MDR1 EXPRESSION BY ANTHRACYCLINES IN A HUMAN MULTIDRUG-RESISTANT CELL-LINE, Clinical cancer research, 2(4), 1996, pp. 713-720
TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA (REPRINTED FROM EUROPEAN JOURNAL OF CANCER, VOL 32A, PG 1945-1954, 1995)
Authors: CUNNINGHAM D ZALCBERG JR RATH U OLVER I VANCUTSEM E SVENSSON C SEITZ JF HARPER P KERR D PEREZMANGA G AZAB M SEYMOUR L LOWERY K
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA (REPRINTED FROM EUROPEAN JOURNAL OF CANCER, VOL 32A, PG 1945-1954, 1995), European journal of cancer, 32A, 1996, pp. 1
FINAL RESULTS OF A RANDOMIZED TRIAL COMPARING TOMUDEX(R) (RALTITREXED) WITH 5-FLUOROURACIL PLUS LEUCOVORIN IN ADVANCED COLORECTAL-CANCER
Authors: CUNNINGHAM D ZALCBERG JR RATH U OLIVER I VANCUTSEM E SVENSSON C SEITZ JF HARPER P KERR D PEREZMANGA G
Citation: D. Cunningham et al., FINAL RESULTS OF A RANDOMIZED TRIAL COMPARING TOMUDEX(R) (RALTITREXED) WITH 5-FLUOROURACIL PLUS LEUCOVORIN IN ADVANCED COLORECTAL-CANCER, Annals of oncology, 7(9), 1996, pp. 961-965
THE ROLE OF 5-FLUOROURACIL DOSE IN THE ADJUVANT THERAPY OF COLORECTAL-CANCER
Authors: ZALCBERG JR SIDEROV J SIMES J
Citation: Jr. Zalcberg et al., THE ROLE OF 5-FLUOROURACIL DOSE IN THE ADJUVANT THERAPY OF COLORECTAL-CANCER, Annals of oncology, 7(1), 1996, pp. 41-46
ZD1694 - A NOVEL THYMIDYLATE SYNTHASE INHIBITOR WITH SUBSTANTIAL ACTIVITY IN THE TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CANCER
Authors: ZALCBERG JR CUNNINGHAM D VANCUTSEM E FRANCOIS E SCHORNAGEL J ADENIS A GREEN M IVESON A AZAB M SEYMOUR I
Citation: Jr. Zalcberg et al., ZD1694 - A NOVEL THYMIDYLATE SYNTHASE INHIBITOR WITH SUBSTANTIAL ACTIVITY IN THE TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 14(3), 1996, pp. 716-721
OUTPATIENT CHEMOTHERAPY - THERES NO PLACE LIKE HOME SOMETIMES
Authors: ZALCBERG JR SIDEROV J PETTY M
Citation: Jr. Zalcberg et al., OUTPATIENT CHEMOTHERAPY - THERES NO PLACE LIKE HOME SOMETIMES, Medical journal of Australia, 165(4), 1996, pp. 182-182
HORMONE REPLACEMENT THERAPY AND BREAST-CANCER - WHAT ARE THE FACTS
Authors: ZALCBERG JR SIDEROV J
Citation: Jr. Zalcberg et J. Siderov, HORMONE REPLACEMENT THERAPY AND BREAST-CANCER - WHAT ARE THE FACTS, Medical journal of Australia, 164(6), 1996, pp. 379-380
THE EUTHANASIA CONTROVERSY - DECISION-MAKING IN EXTREME CIRCUMSTANCES- REPLY
Authors: ZALCBERG JR BUCHANAN JD
Citation: Jr. Zalcberg et Jd. Buchanan, THE EUTHANASIA CONTROVERSY - DECISION-MAKING IN EXTREME CIRCUMSTANCES- REPLY, Medical journal of Australia, 164(5), 1996, pp. 318-318
INHERITANCE OF CHROMOSOME-7 IS ASSOCIATED WITH A DRUG-RESISTANT PHENOTYPE IN SOMATIC-CELL HYBRIDS
Authors: DESILVA M KANTHARIDIS P WALL DM CAMPBELL L VRAZAS V NADALIN G KACZMARCZYK SJ HU XF PARKIN JD ZALCBERG JR
Citation: M. Desilva et al., INHERITANCE OF CHROMOSOME-7 IS ASSOCIATED WITH A DRUG-RESISTANT PHENOTYPE IN SOMATIC-CELL HYBRIDS, British Journal of Cancer, 73(2), 1996, pp. 169-174
MODULATION OF THE FUNCTION OF HUMAN MDR1 P-GLYCOPROTEIN BY THE ANTIMALARIAL DRUG MEFLOQUINE
Authors: RIFFKIN CD CHUNG R WALL DM ZALCBERG JR COWMAN AF FOLEY M TILLEY L
Citation: Cd. Riffkin et al., MODULATION OF THE FUNCTION OF HUMAN MDR1 P-GLYCOPROTEIN BY THE ANTIMALARIAL DRUG MEFLOQUINE, Biochemical pharmacology, 52(10), 1996, pp. 1545-1552
TREATMENT PRINCIPLES IN ADVANCED COLORECTAL-CANCER (VOL 66, PG 202, 1996)
Authors: ZALCBERG JR FRIEDLANDER ML COLLOPY BT BARTON M GRAY B
Citation: Jr. Zalcberg et al., TREATMENT PRINCIPLES IN ADVANCED COLORECTAL-CANCER (VOL 66, PG 202, 1996), Australian and New Zealand journal of surgery, 66(7), 1996, pp. 503-503
TREATMENT PRINCIPLES IN ADVANCED COLORECTAL-CANCER
Authors: ZALCBERG JR FRIEDLANDER ML COLLOPY BT BARTON M GRAY B
Citation: Jr. Zalcberg et al., TREATMENT PRINCIPLES IN ADVANCED COLORECTAL-CANCER, Australian and New Zealand journal of surgery, 66(4), 1996, pp. 202-205
TREATMENT PRINCIPLES IN ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: SCOTT CL ZALCBERG JR IRVING LB
Citation: Cl. Scott et al., TREATMENT PRINCIPLES IN ADVANCED NON-SMALL-CELL LUNG-CANCER, Australian and New Zealand journal of surgery, 66(10), 1996, pp. 688-693
THE ROLE OF CHEMOTHERAPY IN MALIGNANT THYMOMA
Authors: COPERCHINI ML ZALCBERG JR
Citation: Ml. Coperchini et Jr. Zalcberg, THE ROLE OF CHEMOTHERAPY IN MALIGNANT THYMOMA, Australian and New Zealand Journal of Medicine, 26(3), 1996, pp. 423-423
INTERIM RESULTS OF A PHASE-II TRIAL OF DOCETAXEL IN COMBINATION WITH CISPLATIN IN PATIENTS WITH METASTATIC OR LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)
Authors: ZALCBERG JR BISHOP JF MILLWARD MJ ZIMET A LAIRD J BARTER C SEWARD D MCKEAGE MJ FRIEDLANDER ML TONER G BERILLE J BLANC C
Citation: Jr. Zalcberg et al., INTERIM RESULTS OF A PHASE-II TRIAL OF DOCETAXEL IN COMBINATION WITH CISPLATIN IN PATIENTS WITH METASTATIC OR LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 31A, 1995, pp. 1084-1084
TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA
Authors: CUNNINGHAM D ZALCBERG JR RATH U OLVER I VANCUTSEM E SVENSSON C SEITZ JF HARPER P KERR D PEREZMANGA G AZAB M SEYMOUR L LOWERY K ACKLAND SP BASSER RL CLARKE SJ GOLDSTEIN D GREEN MD GRYGIEL JJ MCKENDRICK JJ MILLWARD MJ OLVER IN TATTERSALL MHN THOMSON DB JAKESZ R BUSET M TUENI EA VANCUTSEM EJD BAUER J BESKA F ADENIS A BRUNET R FRANCOIS E PAILLOT B ROUGIER P FINK UFW KNUTH KRA KOENIG HJ BOHME MWJ WANDER HE AMADORI D FRASSINETI L COCCONI G PASSALACQUA R FRIGERIO F BARNI S LUPORINI G LABIANCA R MARINI G ZANIBONI A KLEPP O TVEIT KM WIST E CANDEIAS OFR GOUVEIA JGP MARQUES JCN OLIVEIRA JML CAVALLI F DELMORE GD GOEDHALS L VOROBIOF DA ESTEVE AAI AGUILAR EA TORRES AA RUIPEREZ AC RUBIO ED SUREDA BM MANGA GP ALFONSO PG GUSTAVSSON B JEPPSON B MALMBERG M STARKHAMMAR H SVENSSON JH KEIZER HJ SCHORNAGEL JH OBRIEN M HARPER PG KERR DJ SCARFFE JH TYRELL CJ
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA, European journal of cancer, 31A(12), 1995, pp. 1945-1954
Risultati: 1-25 | 26-39